|
|
|
|
In an era of profound new discoveries and possibilities in biotech and life sciences...
BioAgenda is an independent, non-partisan, non-industry think-tank founded by journalists and critical thinkers with a core mission to discuss, analyze, and study issues and policies, from stem cells to how to pay for new drugs. BioAgenda’s programs include roundtables, exhibits, lectures, and publications to facilitate evocative discussions among leaders, policy-makers, critics and thinkers, with educational initiatives addressed to leaders, students, professionals, and the public.
BioAgenda is dedicated to an autonomous, spirited, unorthodox discussion encompassing all points of view. All content is prepared by distinguished journalists and thinkers, and by the editorial staff of BioAgenda.
|
|
|
Latest News
- The first ever BioAgenda 2004 Summit Is a Success!
Posted: December 27, 2004 8:01 AM
On December 5-7, over 150 leaders in biotechnology and life sciences, including journalists, activists, policy makers, a high school teacher, artists and thinkers, gathered in Palm Springs, on the high desert to discuss and debate stem cells, drug pricing, science and politics, what works and doesn't work in the economics of biotech, and the future of life...
- Nonprofit Biotech Policy Institute Announced
Posted: September 15, 2004 9:35 AM
BioAgenda has filed for nonprofit profit status for a proposed policy institute to be launched in 2005, the first step in creating an organization for biotech policy modeled after the Brookings Institute...
- San Diego Roundtable Big Success
Posted: July 26, 2004 9:16 PM
Is redesigning life a good idea? Bioengineering in the age of genetics – was the topic of BioAgenda’s second successful Regional Issues Roundtable on July 19, 2004 in the San Diego…
- BioAgenda's Statement on Policy of Independence
Posted: June 01, 2004 10:00 AM
As BioAgenda works to diversify its underwriting and to underscore our core mission of independence in our content and offerings, BioAgenda has prepared a “Mission Statement”...
|
|
|
|
|
|
"The themes of this new style conference are fresh and unlike those of the many biotech meetings we all attend. This gathering will bring out intellectual debate among leading scientists, entrepreneurs, legislators, ethicists, and investors on the huge issues of innovation and responsibility that go with the biotechnology revolution."
- Brook Byers, Partner, Kleiner Perkins Caufield and Byers |
|
|
|
